Lazard Asset Management LLC Sells 27,748 Shares of Dolby Laboratories $DLB

Posted by Stanley Muller on Jul 29th, 2026

Lazard Asset Management LLC lessened its stake in shares of Dolby Laboratories (NYSE:DLB – Free Report) by 6.7% during the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 387,100 shares of the electronics maker’s stock after selling 27,748 shares during the period. Lazard Asset Management LLC’s holdings in Dolby Laboratories were worth $23,249,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently bought and sold shares of the company. Fifth Third Bancorp raised its stake in shares of Dolby Laboratories by 34.7% in the fourth quarter. Fifth Third Bancorp now owns 746 shares of the electronics maker’s stock valued at $48,000 after acquiring an additional 192 shares during the period. Aquatic Capital Management LLC purchased a new position in shares of Dolby Laboratories during the 3rd quarter worth about $56,000. iSAM Funds UK Ltd purchased a new position in shares of Dolby Laboratories during the 3rd quarter worth about $68,000. Allworth Financial LP grew its holdings in Dolby Laboratories by 99.6% during the 3rd quarter. Allworth Financial LP now owns 1,006 shares of the electronics maker’s stock valued at $73,000 after purchasing an additional 502 shares during the last quarter. Finally, Quarry LP grew its holdings in Dolby Laboratories by 1,486.7% during the 4th quarter. Quarry LP now owns 1,190 shares of the electronics maker’s stock valued at $76,000 after purchasing an additional 1,115 shares during the last quarter. 58.56% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Dolby Laboratories

In related news, CFO Robert J. Park sold 4,895 shares of the business’s stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $56.68, for a total value of $277,448.60. Following the completion of the sale, the chief financial officer owned 81,490 shares in the company, valued at approximately $4,618,853.20. The trade was a 5.67% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Shriram Revankar sold 3,000 shares of the stock in a transaction that occurred on Friday, May 15th. The stock was sold at an average price of $54.90, for a total value of $164,700.00. Following the completion of the transaction, the senior vice president directly owned 80,603 shares in the company, valued at approximately $4,425,104.70. This trade represents a 3.59% decrease in their position. The SEC filing for this sale provides additional information. In the last three months, insiders sold 47,458 shares of company stock valued at $2,639,537. 37.93% of the stock is owned by insiders.

Analysts Set New Price Targets

Several analysts have issued reports on DLB shares. Wall Street Zen raised shares of Dolby Laboratories from a “hold” rating to a “buy” rating in a research note on Saturday, May 30th. Barrington Research reaffirmed an “outperform” rating and set a $90.00 target price on shares of Dolby Laboratories in a research note on Monday, June 15th. Rosenblatt Securities reiterated a “buy” rating and issued a $85.00 price target on shares of Dolby Laboratories in a report on Thursday, June 11th. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Dolby Laboratories in a research note on Wednesday, June 24th. Three research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $90.75.

Get Our Latest Stock Analysis on DLB

Dolby Laboratories Trading Up 2.3%

NYSE DLB opened at $52.44 on Wednesday. The company’s 50-day moving average price is $52.28 and its 200-day moving average price is $58.74. The stock has a market cap of $4.96 billion, a PE ratio of 20.73 and a beta of 0.81. Dolby Laboratories has a 12 month low of $48.26 and a 12 month high of $76.70.

Dolby Laboratories (NYSE:DLB – Get Free Report) last announced its quarterly earnings data on Thursday, April 30th. The electronics maker reported $1.37 earnings per share for the quarter, beating analysts’ consensus estimates of $1.31 by $0.06. Dolby Laboratories had a net margin of 17.85% and a return on equity of 11.47%. The company had revenue of $395.63 million during the quarter, compared to analyst estimates of $385.80 million. During the same quarter last year, the business posted $1.34 EPS. The firm’s revenue for the quarter was up 7.0% on a year-over-year basis. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. As a group, sell-side analysts forecast that Dolby Laboratories will post 3.21 earnings per share for the current year.

Dolby Laboratories Company Profile

(Free Report)

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.